Cargando…
Association of Higher-Dose Fluoroquinolone Therapy With Serious Adverse Events in Older Adults With Advanced Chronic Kidney Disease
IMPORTANCE: Population-based data are needed to inform the safe prescribing of fluoroquinolone antibiotics to patients with advanced chronic kidney disease (CKD). OBJECTIVE: To quantify the 14-day risk of a hospital visit with nervous system and/or psychiatric disorders, hypoglycemia, or a collagen-...
Autores principales: | Muanda, Flory Tsobo, Sood, Manish M., Weir, Matthew A., Sontrop, Jessica M., Ahmadi, Fatemeh, Yoo, Elisa, Kim, Richard B., Silverman, Michael S., Knoll, Gregory A., Garg, Amit X. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346548/ https://www.ncbi.nlm.nih.gov/pubmed/35917124 http://dx.doi.org/10.1001/jamanetworkopen.2022.24892 |
Ejemplares similares
-
Low-Dose Methotrexate and Serious Adverse Events Among Older Adults With Chronic Kidney Disease
por: Muanda, Flory T., et al.
Publicado: (2023) -
Cardiovascular Safety of Metoclopramide Compared to Domperidone: A Population-Based Cohort Study
por: Cowan, Andrea, et al.
Publicado: (2020) -
Adverse events with quetiapine and clarithromycin coprescription: A population‐based retrospective cohort study
por: Yau, Kevin, et al.
Publicado: (2023) -
Antimalarial drugs for preventing malaria during pregnancy and the risk of low birth weight: a systematic review and meta-analysis of randomized and quasi-randomized trials
por: Muanda, Flory Tsobo, et al.
Publicado: (2015) -
Healthcare costs and mortality associated with serious fluoroquinolone‐related adverse reactions
por: Kuula, Laura S.M., et al.
Publicado: (2022)